Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FLJF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,355
Award facts
- Contract value 100% obligated
- $26,355.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,355.47 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors (2 mL) on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Cosentyx is a prescription biologic medication used to treat various inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, and represents the type of specialized pharmaceutical product critical to military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support Defense Health Agency operations and broader military healthcare systems worldwide. The company's large prime contract vehicle enables flexible procurement of specialty medications, vaccines, and medical commodities across multiple therapeutic domains, with this specific delivery order representing routine fulfillment under that broader agreement.
Quick answers
Who was awarded contract SPE2DB25FLJF3?
SPE2DB25FLJF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FLJF3 worth?
The government has obligated $26,355 on SPE2DB25FLJF3.
Is contract SPE2DB25FLJF3 an order under another contract?
Yes. SPE2DB25FLJF3 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLJF3 competed?
The extent of competition for SPE2DB25FLJF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award